Saba Capital Management »

Liminatus Pharma shares owned by Saba Capital Management

Quarter-by-quarter ownership of Liminatus Pharma (LIMNW) shares owned by Saba Capital Management from 13F filings

Historical chart of Saba Capital Management investment in Liminatus Pharma

Tip: Access up to 7 years of quarterly data

All positions including Liminatus Pharma held by Saba Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Liminatus Pharma by Saba Capital Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 234k 0.15
2025-06-30 $56k 234k 0.24

More positions owned by Saba Capital Management

Blackrock Esg Cap Allc Term Shs Ben Int (ECAT)
Asa Gold And Precious Mtls L SHS (ASA)
Pimco Dynamic Income Strateg Com Shs Ben Int (PDX)
Gabelli Dividend & Income Trust (GDV)
General American Investors (GAM)
Neuberger Berman Next Genera Common Stock (NBXG)
Nfj Dividend Interest (NFJ)
Mainstay Cbre Global (MEGI)
Boeing Company Put Option (BA)
Advanced Micro Devices Put Option (AMD)
Blackrock Science & Technolo Shs Ben Int (BSTZ)
NVIDIA Corporation Put Option (NVDA)
Western Digital Put Option (WDC)
Petroleum & Res Corp Com cef (PEO)
Nuveen PA Investnt Quality Municipal (NQP)

View all positions for Saba Capital Management

Top funds holding Liminatus Pharma

Clear Street
Aristeia Capital
Linden Advisors
Saba Capital Management
Highbridge Capital Management
Moore Capital Management
Polar Securities
MMCAP International Inc. SPC
Nomura Holdings
Falcon Edge Capital
D. E. Shaw & Co
Millennium Management
Wolverine Asset Management
Blue Owl Capital Holdings
Periscope Capital

View all funds holding Liminatus Pharma